Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil effect on POV in pediatric strabismus surgery
NCT02455401Completed
- Sponsor
- Inje University
- Start
- May 2015
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of remifentanil in strabismus (3 arms), sponsored by Inje University. Primary endpoint: Incidence of Postoperative Vomiting at 24 hours. Started May 2015; status: completed.
02
Drugs
remifentanil
03
Conditions
strabismus
Beyond the preview
Go deeper on NCT02455401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455401.